Skip to main content Skip to accessibility
This website is not compatible with your web browser. You should install a newer browser. If you live in Jersey and need help upgrading call the States of Jersey web team on 440099.
Government of Jerseygov.je

Information and public services for the Island of Jersey

L'înformâtion et les sèrvices publyis pouor I'Île dé Jèrri

  • Choose the service you want to log in to:

  • gov.je

    Update your notification preferences

  • one.gov.je

    Access government services

  • CAESAR

    Clear goods through customs or claim relief

  • Talentlink

    View or update your States of Jersey job application

Health Insurance (Jersey) Law 1967: Prescribed list as of 1st April 2020

A formal published “Ministerial Decision” is required as a record of the decision of a Minister (or an Assistant Minister where they have delegated authority) as they exercise their responsibilities and powers.

Ministers are elected by the States Assembly and have legal responsibilities and powers as “corporation sole” under the States of Jersey Law 2005 by virtue of their office and in their areas of responsibility, including entering into agreements, and under any legislation conferring on them powers.

An accurate record of “Ministerial Decisions” is vital to effective governance, including:

  • demonstrating that good governance, and clear lines of accountability and authority, are in place around decisions-making – including the reasons and basis on which a decision is made, and the action required to implement a decision

  • providing a record of decisions and actions that will be available for examination by States Members, and Panels and Committees of the States Assembly; the public, organisations, and the media; and as a historical record and point of reference for the conduct of public affairs

Ministers are individually accountable to the States Assembly, including for the actions of the departments and agencies which discharge their responsibilities.

The Freedom of Information Law (Jersey) Law 2011 is used as a guide when determining what information is be published. While there is a presumption toward publication to support of transparency and accountability, detailed information may not be published if, for example, it would constitute a breach of data protection, or disclosure would prejudice commercial interest.

A decision made on 6 March 2020

Decision Reference:  MD-S-2020-0014

Decision Summary Title :

DS Prescribed list as of 1 April 2020

Date of Decision Summary:

27 February 2020

Decision Summary Author:

Policy Principal

Decision Summary:

Public or Exempt?

Public

Type of Report:

Oral or Written?

Written

Person Giving

Oral Report:

NA

Written Report

Title :

WR Prescribed list as of 1 April 2020

Date of Written Report:

17 February 2020

Written Report Author:

Prescribing Advisor

Written Report :

Public or Exempt?

 

Public

Subject: Changes to be made to the Prescribed List (Jersey) as of 1 April 2020

Decision(s): Further to Article 15, paragraphs (11) and (12), of the Health Insurance (Jersey) Law 1967, and having consulted with the Pharmaceutical Benefit Advisory Committee, the Minister decided to make amendments to the Prescribed List with effect from 1 March 2020 as set out in the accompanying report and supporting document.

Reason(s) for Decision: The Pharmaceutical Benefit Advisory Committee met to consider  applications for changes to the Prescribed List and made the following recommendations:  

1.      Items to be added to the Prescribed List

1.1     Ticagrelor 60mg tablets (interim recommendation November 2019)

1.2     Sodium hyaluronate 0.2% eye drops preservative free

1.3     VitA-POS™֥ eye ointment preservative free

1.4     Colesevelam 625mg tablets

1.5     Colestipol 5g granules sachets sugar free

1.6     Mesalazine 1g suppositories

1.7     Trimbow™ 87micrograms/dose / 5micrograms/dose / 9micrograms/dose inhaler

1.8     Rivaroxaban 2.5mg tablets, 10mg tablets

1.9     Captopril 25mg/5ml oral solution sugar free

1.10          Aciclovir eye ointment (temporary reinstatement for 6 months only to allow for pharmacy stock to be used up)

 

  1. Items to be removed from the Prescribed List

 

 Removal from April 2021:

2.1 Pethidine tablets

2.2 Flurazepam capsules

 

Removal from July 2020:

2.3 Pethidine injection

2.4 Aminophylline injection

2.5 Danazol capsules

2.6 Demeclocycline capsules

2.7 Diethylstilbestrol 5mg tablet

2.8 Dihydrocodeine injection

2.9 Disopyramide injection

2.10 Ephedrine injection

2.11 Fentanyl injection

2.12 Pergolide tablets

2.13 Sodium cromoglicate caps 100mg

2.14 Uvistat sun screen Factor 30

2.15 Phenelzine tablets

2.16 Phenindione tablets

2.17 Phenoxybenzamine capsules

2.18          Pimozide tablets

 

  1. Other changes to the Prescribed List

The following two products were recommended for reimbursement as ‘Generic only’.

3.1 Budesonide 64micrograms/dose nasal spray

3.2 Bimatoprost 300micrograms/ml eye drops

 

The recommendation reflects current evidence and expert advice and ensure that patients in Jersey have access to an appropriate range of modern, safe and effective treatments from their GPs and community prescribers at a proportionate cost to the Fund.

 

 

Resource Implications: The overall financial impact of the above changes is expected to be cost neutral.  

 

Action required: Work and Family Hub Manager at Customer and Local Services to issue a public notice listing amendments and notify all approved medical practitioners and approved contractors.

Signature:

 

 

 

Deputy J A Martin

Position:

 

Minister for Social Security

 

Date Signed:

 

 

Date of Decision (If different from Date Signed):

 

Back to top
rating button